Literature DB >> 10449602

Estimates of the worldwide mortality from 25 cancers in 1990.

P Pisani1, D M Parkin, F Bray, J Ferlay.   

Abstract

We present here worldwide estimates of annual mortality from all cancers and for 25 specific cancer sites around 1990. Crude and age-standardised mortality rates and numbers of deaths were computed for 23 geographical areas. Of the estimated 5.2 million deaths from cancer (excluding non-melanoma skin cancer), 55% (2.8 million) occurred in developing countries. The sex ratio is 1.33 (M:F), greater than that of incidence (1.13) due to the more favourable prognosis of cancer in women. Lung cancer is still the most common cause of death from cancer worldwide with over 900,000 deaths per year, followed by gastric cancer with over 600,000 deaths and colorectal and liver cancers accounting for at least 400,000 deaths each. In men, deaths from liver cancer exceed those due to colo-rectal cancer by 38%. Over 300,000 deaths of women are attributed to breast cancer, which remains the leading cause of death from cancer in women, followed by cancers of the stomach and lung with 230,000 annual deaths each. In men, the risk of dying from cancer is highest in eastern Europe, with an age-standardised rate for all sites of 205 deaths per 100,000 population. Mortality rates in all other developed regions are around 180. The only developing area with an overall rate of the same magnitude as that in developed countries is southern Africa. All of eastern Asia, including China, has mortality rates above the world average, as do all developed countries. The region of highest risk among women is northern Europe (age-standardised rate = 125.4), followed by North America, southern Africa and tropical South America. Only south-central and western Asia (Indian subcontinent, central Asia and the middle-eastern countries) and Northern Africa are well below the world average of 90 deaths per 100,000 population annually. Our results indicate the potential impact of preventive practices. It is estimated that 20% of all cancer deaths (1 million) could be prevented by eliminating tobacco smoking. Infectious agents account for a further 16% of deaths. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10449602     DOI: 10.1002/(sici)1097-0215(19990924)83:1<18::aid-ijc5>3.0.co;2-m

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  302 in total

1.  The epidemiology of stomach cancer: correlating the past with the present. Socioeconomic influences in early life can influence mortality in adult life.

Authors:  D Forman; K J Goodman
Journal:  BMJ       Date:  2000-06-24

2.  Cervical cancer in the developing world.

Authors:  J Sherris; C Herdman; C Elias
Journal:  West J Med       Date:  2001-10

3.  Opposing action of estrogen receptors alpha and beta on tumor necrosis factor-alpha gene expression and caspase-8-mediated apoptotic effects in HA22T cells.

Authors:  Erh-Jung Huang; Cheng-Chung Wu; Shin-Da Lee; Juen-Hau Chen; Jer-Yuh Liu; Jiunn-Liang Ko; James A Lin; Min-Chi Lu; Li-Mien Chen; Chih-Yang Huang; Wei-Wen Kuo
Journal:  Mol Cell Biochem       Date:  2006-04-22       Impact factor: 3.396

4.  The abnormalities of chromosome 8 in two hepatocellular carcinoma cell clones with the same genetic background and different metastatic potential.

Authors:  Jiong Yang; Lun-Xiu Qin; Sheng-Long Ye; Yin-Kun Liu; Yan Li; Dong-Mei Gao; Jie Chen; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2003-05-15       Impact factor: 4.553

5.  Screening for prostate cancer using multivariate mixed-effects models.

Authors:  Christopher H Morrell; Larry J Brant; Shan Sheng; E Jeffrey Metter
Journal:  J Appl Stat       Date:  2012-06-01       Impact factor: 1.404

6.  Application of linear discriminant analysis and Attenuated Total Reflectance Fourier Transform Infrared microspectroscopy for diagnosis of colon cancer.

Authors:  Mohammadreza Khanmohammadi; Amir Bagheri Garmarudi; Simin Samani; Keyvan Ghasemi; Ahmad Ashuri
Journal:  Pathol Oncol Res       Date:  2010-12-31       Impact factor: 3.201

Review 7.  CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting.

Authors:  Hyo Jin Lee; Ik-Chan Song; Hwan-Jung Yun; Deog-Yeon Jo; Samyong Kim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

8.  Retrospective analysis of HPV 16/18-related disease burden using archival clinical samples.

Authors:  Naureen Ehsan Ilahi; Shoaib Naiyar Hashmi; Sobia Anwar; Sheeba Murad
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-30       Impact factor: 4.553

9.  Gastric cancer-a clinicopathological study in a tertiary care centre of North-eastern India.

Authors:  Arun Kumar Barad; Sanjeet Kumar Mandal; Hiriyur S Harsha; Birkumar M Sharma; Th Sudhirchandra Singh
Journal:  J Gastrointest Oncol       Date:  2014-04

10.  p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis.

Authors:  L Sivaraman; O M Conneely; D Medina; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.